Anemia Studies in Chronic Kidney Disease: Erythropoiesis Via a Novel Prolyl Hydroxylase Inhibitor Daprodustat-Non-Dialysis (ASCEND-ND)
Clinical trial NCT02876835 · COMPLETED
Trial details
- NCT number
- NCT02876835
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2016-09-27
- Primary completion
- 2021-04-19
- Enrollment
- 3872
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.